The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
A targeted proteomics–based pipeline for verification of biomarkers in plasma
Open accessAbstract
High-throughput technologies can now identify hundreds of candidate protein biomarkers for any disease with relative ease. However, because there are no assays for the majority of proteins and de novo immunoassay development is prohibitively expensive, few candidate biomarkers are tested in clinical studies. We tested whether the analytical performance of a biomarker identification pipeline based on targeted mass spectrometry would be sufficient for data-dependent prioritization of candidate biomarkers, de novo development of assays and multiplexed biomarker verification. We used a data-dependent triage process to prioritize a subset of putative plasma biomarkers from >1,000 candidates previously identified using a mouse model of breast cancer. Eighty-eight novel quantitative assays based on selected reaction monitoring mass spectrometry were developed, multiplexed and evaluated in 80 plasma samples. Thirty-six proteins were verified as being elevated in the plasma of tumor-bearing animals. The analytical performance of this pipeline suggests that it should support the use of an analogous approach with human samples.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Skyline: an open source document editor for creating and analyzing targeted proteomics experiments
MacLean, B., Tomazela, D. M., Shulman, N., Chambers, M., Finney, G. L., Frewen, B., Kern, R., Tabb, D. L., Liebler, D. C., & MacCoss, M. J. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq054 · Cited by 4,697
Protein biomarker discovery and validation: the long and uncertain path to clinical utility
Rifai, N., Gillette, M. A., & Carr, S. A. (2006) · Nature Biotechnology · doi:10.1038/nbt1235 · Cited by 1,867
Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS
Gerber, S. A., Rush, J., Stemman, O., Kirschner, M. W., & Gygi, S. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0832254100 · Cited by 1,733
Selected reaction monitoring for quantitative proteomics: a tutorial
Lange, V., Picotti, P., Domon, B., & Aebersold, R. (2008) · Molecular Systems Biology · doi:10.1038/msb.2008.61 · Cited by 1,407
Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins
Anderson, L., & Hunter, C. L. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500331-mcp200 · Cited by 1,230
Anderson, N. L., Anderson, N. G., Haines, L. R., Hardie, D. B., Olafson, R. W., & Pearson, T. W. (2004) · Journal of Proteome Research · doi:10.1021/pr034086h · Cited by 804
Keshishian, H., Addona, T., Burgess, M., Kuhn, E., & Carr, S. A. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700354-mcp200 · Cited by 684
Biological Variation: From Principles to Practice
Fraser, C. G. (2001) · Cited by 653
Bordeaux, J., Welsh, A. W., Agarwal, S., Killiam, E., Baquero, M. T., Hanna, J. A., Anagnostou, V. K., & Rimm, D. L. (2010) · BioTechniques · doi:10.2144/000113382 · Cited by 589
The Clinical Plasma Proteome: A Survey of Clinical Assays for Proteins in Plasma and Serum
Anderson, N. L. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.126706 · Cited by 562
The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry
Hoofnagle, A. N., & Wener, M. H. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2009.06.003 · Cited by 561
High-throughput generation of selected reaction-monitoring assays for proteins and proteomes
Picotti, P., Rinner, O., Stallmach, R., Dautel, F., Farrah, T., Domon, B., Wenschuh, H., & Aebersold, R. (2010) · Nature Methods · doi:10.1038/nmeth.1408 · Cited by 453
Kuhn, E., Wu, J., Karl, J., Liao, H., Zolg, W., & Guild, B. (2004) · PROTEOMICS · doi:10.1002/pmic.200300670 · Cited by 398
Mass Spectrometry Based Targeted Protein Quantification: Methods and Applications
Pan, S., Aebersold, R., Chen, R., Rush, J., Goodlett, D. R., McIntosh, M. W., Zhang, J., & Brentnall, T. A. (2009) · Journal of Proteome Research · doi:10.1021/pr800538n · Cited by 396
Self-citationHigh Sensitivity Detection of Plasma Proteins by Multiple Reaction Monitoring of N-Glycosites
Stahl-Zeng, J., Lange, V., Ossola, R., Eckhardt, K., Krek, W., Aebersold, R., & Domon, B. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700132-mcp200 · Cited by 361
Barr, J. R., Maggio, V. L., Patterson, D. G., Cooper, G. R., Henderson, L. O., Turner, W. E., Smith, S. J., Hannon, W. H., Needham, L. L., & Sampson, E. J. (1996) · Clinical Chemistry · doi:10.1093/clinchem/42.10.1676 · Cited by 347
Moody, S. E., Sarkisian, C. J., Hahn, K. T., Gunther, E. J., Pickup, S., Dugan, K. D., Innocent, N., Cardiff, R. D., Schnall, M. D., & Chodosh, L. A. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00212-x · Cited by 345
Self-citationWhiteaker, J. R., Zhao, L., Anderson, L., & Paulovich, A. G. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900254-mcp200 · Cited by 323
Self-citationHoofnagle, A. N., Becker, J. O., Wener, M. H., & Heinecke, J. W. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.109652 · Cited by 314 · cited 1×
“(SISCAPA), achieves limits of quantification (LOQ) of proteins in the low ng protein/ml rang”
Keshishian, H., Addona, T., Burgess, M., Mani, D. R., Shi, X., Kuhn, E., Sabatine, M. S., Gerszten, R. E., & Carr, S. A. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900140-mcp200 · Cited by 286
Barnidge, D. R., Goodmanson, M. K., Klee, G. G., & Muddiman, D. C. (2004) · Journal of Proteome Research · doi:10.1021/pr049963d · Cited by 253
The Expanding Role of Mass Spectrometry in Metabolite Profiling and Characterization
Want, E. J., Cravatt, B. F., & Siuzdak, G. (2005) · ChemBioChem · doi:10.1002/cbic.200500151 · Cited by 249
Kuhn, E., Addona, T., Keshishian, H., Burgess, M., Mani, D. R., Lee, R. T., Sabatine, M. S., Gerszten, R. E., & Carr, S. A. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.123935 · Cited by 247
Paulovich, A. G., Whiteaker, J. R., Hoofnagle, A. N., & Wang, P. (2008) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.200780174 · Cited by 231
Self-citationA Human Proteome Detection and Quantitation Project
Anderson, N. L., Anderson, N. G., Pearson, T. W., Borchers, C. H., Paulovich, A. G., Patterson, S. D., Gillette, M., Aebersold, R., & Carr, S. A. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r800015-mcp200 · Cited by 200
Self-citationWhiteaker, J. R., Zhang, H., Zhao, L., Wang, P., Kelly-Spratt, K. S., Ivey, R. G., Piening, B. D., Feng, L.-C., Kasarda, E., Gurley, K. E., et al. (2007) · Journal of Proteome Research · doi:10.1021/pr070202v · Cited by 179
Self-citationIncreased Selectivity, Analytical Precision, and Throughput in Targeted Proteomics
Kiyonami, R., Schoen, A., Prakash, A., Peterman, S., Zabrouskov, V., Picotti, P., Aebersold, R., Huhmer, A., & Domon, B. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.002931 · Cited by 177
Makawita, S., & Diamandis, E. P. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.127019 · Cited by 168
Accurate Inclusion Mass Screening
Jaffe, J. D., Keshishian, H., Chang, B., Addona, T. A., Gillette, M. A., & Carr, S. A. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800218-mcp200 · Cited by 155
Protein Quantitation through Targeted Mass Spectrometry: The Way Out of Biomarker Purgatory?
Carr, S. A., & Anderson, L. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.114686 · Cited by 141
Whiteaker, J. R., Zhao, L., Abbatiello, S. E., Burgess, M. W., Kuhn, E. W., Lin, C., Pope, M. E., Razavi, M., Anderson, N. L., Pearson, T. W., et al. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.005645 · Cited by 135
Self-citationWu, S., Amato, H., Biringer, R. G., Choudhary, G., Shieh, P., & Hancock, W. S. (2002) · Journal of Proteome Research · doi:10.1021/pr025537l · Cited by 123
The Roles of Multiple Proteomic Platforms in a Pipeline for New Diagnostics
Anderson, N. L. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.i500001-mcp200 · Cited by 120
Point On the meaning of “sensitivity”
Ekins, R. P., & Edwards, P. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.10.1824 · Cited by 116
Zhang, H., Liu, Q., Zimmerman, L. J., Ham, A. L., Slebos, R. J. C., Rahman, J. S. M., Kikuchi, T., Massion, P. P., Carbone, D. P., Billheimer, D. D., et al. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.006593 · Cited by 113
Multiomic Analysis Reveals Disruption of Cholesterol Homeostasis by Cannabidiol in Human Cell Lines
Guard, S. E., Chapnick, D. A., Poss, Z. C., Ebmeier, C. C., Jacobsen, J. R., Nemkov, T. G., Ball, K. A., Webb, K. J., Simpson, H. L., Coleman, S. J., et al. (2022) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2022.100262 · Cited by 90
The evolving role of mass spectrometry in cancer biomarker discovery
Wang, P., Whiteaker, J. R., & Paulovich, A. G. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.12.8634 · Cited by 79
Self-citationA Reagent Resource to Identify Proteins and Peptides of Interest for the Cancer Community
Haab, B. B., Paulovich, A. G., Anderson, N. L., Clark, A. M., Downing, G. J., Hermjakob, H., LaBaer, J., & Uhlén, M. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.t600020-mcp200 · Cited by 74
Self-citationCooney, J. D. (1966) · Zeitschrift für Ägyptische Sprache und Altertumskunde · doi:10.1524/zaes.1966.93.12.43 · Cited by 64
Omenn, G. S., Yocum, A. K., & Menon, R. (2010) · Disease Markers · doi:10.1155/2010/705847 · Cited by 59
Schoenherr, R. M., Zhao, L., Whiteaker, J. R., Feng, L.-C., Li, L., Liu, L., Liu, X., & Paulovich, A. G. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2009.11.017 · Cited by 57
Self-citationAffinity reagent resources for human proteome detection: Initiatives and perspectives
Stoevesandt, O., & Taussig, M. (2007) · PROTEOMICS · doi:10.1002/pmic.200700155 · Cited by 55
Restructuring Proteomics Through Verification
Boja, E. S., Rivers, R. C., Kinsinger, C. R., Mesri, M., Hiltke, T., Rahbar, A. M., & Rodriguez, H. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.10.92 · Cited by 28
Proteome and transcriptome profiles of a Her2/Neu‐driven mouse model of breast cancer
Schoenherr, R. M., Kelly‐Spratt, K. S., Lin, C., Whiteaker, J. R., Liu, T., Holzman, T., Coleman, I. M., Feng, L., Lorentzen, T. D., Krasnoselsky, A. L., et al. (2011) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201000037 · Cited by 13
Self-citation
Cited by
Peterson, A. C., Russell, J. D., Bailey, D. J., Westphall, M. S., & Coon, J. J. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o112.020131 · Cited by 1,288
Revisiting biomarker discovery by plasma proteomics
Geyer, P. E., Holdt, L. M., Teupser, D., & Mann, M. (2017) · Molecular Systems Biology · doi:10.15252/msb.20156297 · Cited by 917
Next-generation proteomics: towards an integrative view of proteome dynamics
Altelaar, A. F. M., Munoz, J., & Heck, A. J. R. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3356 · Cited by 782
Using i RT, a normalized retention time for more targeted measurement of peptides
Escher, C., Reiter, L., MacLean, B., Ossola, R., Herzog, F., Chilton, J., MacCoss, M. J., & Rinner, O. (2012) · PROTEOMICS · doi:10.1002/pmic.201100463 · Cited by 600
Carr, S. A., Abbatiello, S. E., Ackermann, B. L., Borchers, C., Domon, B., Deutsch, E. W., Grant, R. P., Hoofnagle, A. N., Hüttenhain, R., Koomen, J. M., et al. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.036095 · Cited by 561
Self-citation
Metadata
- Authors
- Whiteaker, J. R., Lin, C., Kennedy, J., Hou, L., Trute, M., Sokal, I., Yan, P., Schoenherr, R. M., Zhao, L., Voytovich, U. J., Kelly-Spratt, K. S., Krasnoselsky, A., Gafken, P. R., Hogan, J. M., Jones, L. A., Wang, P., Amon, L., Chodosh, L. A., Nelson, P. S., McIntosh, M. W., Kemp, C. J., & Paulovich, A. G.
- Venue
- Nature Biotechnology
- Published
- 2011-06-19
- Volume
- 29
- Issue
- 7
- Pages
- 625-634
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W1964753682
- Cited by
- 364
- References
- 44
- FWCI
- 22.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.